Ayse Leyla Mindikoglu, M.D., M.P.H.

Associate Professor of Medicine and Surgery
Baylor College of Medicine

Ayse Leyla Mindikoglu, M.D., M.P.H. Photo

Position

Associate Professor of Medicine and Surgery
Margaret M. and Albert B. Alkek Department of Medicine, Section of Gastroenterology and Hepatology
Michael E. DeBakey Department of Surgery, Division of Abdominal Transplantation
Baylor College of Medicine

Address

Baylor Clinic (Clinic)
6620 Main Street
Suite 1450
Houston, Texas 77030
United States
Google Maps

Certifications

  • Internal Medicine American Board of Internal Medicine

  • Gastroenterology American Board of Internal Medicine

  • Transplant Hepatology American Board of Internal Medicine

Education

  • Fellowship at University of Miami Leonard M. Miller School of Medicine
    06/2005 - Miami, Florida United States

    Advanced Hepatology

  • Fellowship at Loyola University Medical Center
    06/2004 - Maywood, Illinois United States

    Gastroenterology and Hepatology

  • Residency at Bronx-Lebanon Hospital Center
    06/2001 - Bronx, New York United States

    Internal Medicine

  • Residency at University of Istanbul, Cerrahpasa Faculty of Medicine
    Istanbul Turkey

    General Surgery (1995-1998)

  • MD from University of Istanbul, Cerrahpasa Faculty of Medicine
    07/1995 - Istanbul Turkey
  • MPH from University of Maryland Baltimore
    12/2007 - Baltimore, Maryland United States

    Master of Public Health

    Epidemiology and Biostatistics Track

Gender

  • Female

Professional Statement

Dr. Ayse Leyla Mindikoglu is board-certified in Internal Medicine, Gastroenterology and Transplant Hepatology with over 14 years of experience in academic clinical practice. Dr. Mindikoglu's current research investigates the effect of intermittent fasting from dawn to sunset on human serum proteome and metabolism in healthy subjects and subjects with metabolic syndrome and nonalcoholic fatty liver disease. Additionally, Dr. Mindikoglu's research has been focused on renal dysfunction and acute kidney injury in cirrhosis, and the development of new biomarkers of glomerular filtration rate in cirrhosis. Supported by the NIH/NIDDK K23 award between 2010 and 2015, and Roderick D. MacDonald Research Award/Baylor St. Luke's Medical Center between 2017 and 2019, Dr. Mindikoglu conducted several clinical studies to understand key concepts of altered renal hemodynamics in cirrhosis and develop metabolomic biomarkers of cirrhosis.

Professional Achievements

  • 2010 Mentored Patient-Oriented Research Career Development Award (National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases K23)

  • 2019 Roderick D. MacDonald Research Award/Baylor St. Luke's Medical Center

  • 2017 Roderick D. MacDonald Research Award/Baylor St. Luke's Medical Center

  • 2017 Faculty Research Award, Baylor College of Medicine, Michael E. DeBakey Department of Surgery (Dr. Mindikoglu declined this award due to an another successful overlapping award)

  • 2004 American Association for the Study of Liver Diseases Advanced Hepatology Fellowship Award

  • 2011 Presidential Poster of Distinction at the Liver Meeting 2011 of the American Association of the Study for Liver Diseases (AASLD), San Francisco, CA

  • 2019 Fellow, American Association for the Study of Liver Diseases

  • 2002 Travel Grant for the 8th Methodologies in Healthcare Outcomes in Gastroenterology Workshop Symposium sponsored by Gastroenterology Research Group (GRG) and the American Gastroenterological Association (AGA)

  • 2002 Third Place Abstract Presentation in Annual Research Prize Competition of the Chicago Society for Gastroenterology

  • 2002 Winner of the Biannual Chicago Academic Debate entitled “Liver Disease: Controversies in the New Millennium”

  • 2017 Poster of Distinction at Digestive Disease Week®, Chicago, IL

Professional Interests

  • Cirrhosis and complications (Ascites, esophageal/gastric varices, gastric antral vascular ectasia, portal hypertensive gastropathy, encephalopathy, hepatocellular carcinoma, hepatorenal syndrome, portopulmonary syndrome, hepatopulmonary syndrome)

  • Chronic liver diseases (e.g. Fatty liver, hepatitis B, hepatitis C, autoimmune hepatitis, alcoholic hepatitis, primary biliary cholangitis, primary sclerosing cholangitis, Wilson disease, hemochromatosis, drug-induced liver injury)

  • Acute liver failure

  • Benign and malignant liver tumors

  • Liver transplantation (Evaluation for liver transplantation and simultaneous liver- kidney, liver-heart, liver-lung and liver-multiorgan transplantation)

  • Post-liver transplant management (Acute and chronic liver graft rejection, immunosuppressive medication management, treatment of post-liver transplant recurrent hepatitis and liver disease)

  • Endoscopy (Esophagogastroduodenoscopy, variceal banding, colonoscopy)